Home > Browse Research > Life Sciences > Pharmaceuticals > Therapeutic Area > Men's Health

Men's Health

Find the information you need on the men's health market. Our collection of research reports provides insights into product and market trends, analysis, opportunities, projections, sales, marketing strategies and growth in the US and global markets.

All reports in Men's Health

Triple Analysis: Melanoma, Prostate Cancer and Protein Kinase Inhibitors 5/1/2012 \| published by: BioSeeker Group AB ... in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between ... \| more...	$5,175.00
Triple Analysis: Prostate Cancer, Cancer Vaccines and Protein Kinase Inhibitors 5/1/2012 \| published by: BioSeeker Group AB ... standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but ... \| more...	$5,175.00
Triple Analysis: Prostate Cancer, Protein Kinase Inhibitors and Antibodies 5/1/2012 \| published by: BioSeeker Group AB ... evaluated according to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer ... \| more...	$5,175.00
Triple Analysis: Breast Cancer, Prostate Cancer and Protein Kinase Inhibitors 5/1/2012 \| published by: BioSeeker Group AB ... criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also ... \| more...	$5,175.00
Triple Analysis: Lung Cancer, Prostate Cancer and Protein Kinase Inhibitors 5/1/2012 \| published by: BioSeeker Group AB ... criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also ... \| more...	$5,175.00
Triple Analysis: Prostate Cancer, Apoptosis and Protein Kinase Inhibitors 5/1/2012 \| published by: BioSeeker Group AB ... criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also ... \| more...	$5,175.00
Triple Analysis: Prostate Cancer, Protein Kinase Inhibitors and Peptides 5/1/2012 \| published by: BioSeeker Group AB ... evaluated according to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer ... \| more...	$5,175.00
Prostate Cancer Market Info™ 3/1/2012 \| published by: Drug Market Info ... the gland. If prostate cancer is detected and treated prior to spreading, 10-yr survival is over 90%. Treating prostate cancer is challenging because many tumors are indolent, not requiring treatment, while other tumors are aggressive ... \| more... Search inside this report	$7,950.00
Testosterone Replacement Therapy (TRT) 3/1/2012 \| published by: Global Industry Analysts ... separate comprehensive analytics for the US, Canada, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2009 through 2017. Also, a six-year historic analysis is provided for ... \| more...	$4,600.00
Triple Analysis: Pancreatic Cancer, Prostate Cancer and Protein Kinase Inhibitors 3/1/2012 \| published by: BioSeeker Group AB ... criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also ... \| more...	$5,175.00
Premature Ejaculation – Pipeline Review, H1 2012 2/27/2012 \| published by: Global Markets Direct ... for Premature Ejaculation, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Premature Ejaculation. 'Premature Ejaculation - Pipeline Review, H1 2012' ... \| more... Search inside this report	$500.00
Prostate Cancer – Pipeline Review, H1 2012 2/27/2012 \| published by: Global Markets Direct ... for Prostate Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Prostate Cancer. 'Prostate Cancer - Pipeline Review, H1 2012' ... \| more... Search inside this report	$500.00
Erectile Dysfunction – Pipeline Review, H1 2012 2/27/2012 \| published by: Global Markets Direct ... for Erectile Dysfunction, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Erectile Dysfunction. 'Erectile Dysfunction - Pipeline Review, H1 2012' ... \| more... Search inside this report	$500.00
Male Hypogonadism – Pipeline Review, H1 2012 2/27/2012 \| published by: Global Markets Direct ... for Male Hypogonadism, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Male Hypogonadism. 'Male Hypogonadism - Pipeline Review, H1 2012' ... \| more... Search inside this report	$500.00
Analytical Tool - Prostate Cancer 2/21/2012 \| published by: BioSeeker Group AB ... of the research and development, a history of the achievements up to date, and a guide pointing out the directions of the future. The product as well, lays the framework of current treatment strategies and ... \| more...	$4,650.00
Prostate Cancer Drug Pipeline Update 2012 2/21/2012 \| published by: BioSeeker Group AB ... LHRH agonist depot formulations. Safety concerns with AstraZeneca`s Casodex (bicalutamide) have also seen a significant proportion of physicians switching to alternatives. Establishing the optimal timing of antihormonal therapy will provide the key to market growth. ... \| more...	$2,249.00
Male Hypogonadism Global Clinical Trials Review, H1, 2012 2/20/2012 \| published by: GlobalData ... and data relating to the clinical trials on Male Hypogonadism. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers ... \| more... Search inside this report	$1,000.00
Erectile Dysfunction Global Clinical Trials Review, H1, 2012 2/20/2012 \| published by: GlobalData ... and data relating to the clinical trials on Erectile Dysfunction. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers ... \| more... Search inside this report	$1,000.00
Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Global Clinical Trials Review, H1, 2012 1/31/2012 \| published by: GlobalData ... Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer. It includes an overview of ... \| more... Search inside this report	$1,000.00
Penile Cancer Global Clinical Trials Review, H1, 2012 1/31/2012 \| published by: GlobalData ... and data relating to the clinical trials on Penile Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers ... \| more... Search inside this report	$1,000.00
Penile Cancer - Pipeline Review, H1 2012 1/23/2012 \| published by: Global Markets Direct ... for Penile Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Penile Cancer. 'Penile Cancer - Pipeline Review, H1 2012' ... \| more... Search inside this report	$500.00
Men's Health Therapeutics Market to 2017 - Availability of Generic Sildenafil from 2012 to Restrain Market Growth 1/16/2012 \| published by: GBI Research ... 2017 - Availability of Generic Sildenafil from 2012 to Restrain Market Growth”. The report provides in-depth analysis of drivers and barriers that impact the global men’s health therapeutics market. The report analyzes the markets for ... \| more... Search inside this report	$3,500.00
Testicular Cancer Global Clinical Trials Review, H2, 2011 12/31/2011 \| published by: GlobalData ... and data relating to the clinical trials on Testicular Cancer . It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook ... \| more... Search inside this report	$1,000.00
Prostate Cancer Global Clinical Trials Review, H2, 2011 12/19/2011 \| published by: GlobalData ... and data relating to the clinical trials on Prostate Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers ... \| more... Search inside this report	$1,000.00
Erectile Dysfunction Therapeutics - Pipeline Assessment and Market Forecasts to 2018 12/5/2011 \| published by: GlobalData ... is an essential source of information and analysis on the global ED therapeutics market. The report identifies the key trends shaping and driving the global ED therapeutics market. The report also provides insights on the ... \| more... Search inside this report	$3,500.00

< prev 1 2 3 4 5 6 next >

Matching Geography

Research Assistance

Start New Browse

Free Alert Me service

Men's Health

Find the information you need on the men's health market. Our collection of research reports provides insights into product and market trends, analysis, opportunities, projections, sales, marketing strategies and growth in the US and global markets.

All reports in Men's Health